Safety and efficacy of drospirenone used in a continuous combination with 17beta-estradiol for prevention of postmenopausal osteoporosis.
about
Hormone therapy in postmenopausal women and risk of endometrial hyperplasiaHormone therapy in postmenopausal women and risk of endometrial hyperplasiaHormone replacement therapy with estradiol and drospirenone: an overview of the clinical data.Pharmacology of different progestogens: the special case of drospirenone.Effects of drospirenone/estrogen combinations on bone metabolism.Drospirenone and estradiol: a new option for the postmenopausal woman.Advances in hormone replacement therapy: weight benefits of drospirenone, a 17alpha-spirolactone-derived progestogen.The endometrium--from estrogens alone to TSECs.Combination of drospirenone and estradiol: a new hormone therapy in postmenopausal women.One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women.Clinical and metabolic effects of drospirenone-estradiol in menopausal women: a prospective study.
P2860
Q24201543-86D7753C-C898-4464-97A8-CEE4FC328496Q24241713-D7736D14-C855-40B8-B86F-8391A0D98B76Q31033397-38FCFFA7-AF12-4E6A-A0A1-FC949C97AD51Q36276322-E996AA4C-96EA-4637-A071-5C6D03E112F5Q36276339-DB002559-27D5-42B3-A0EF-A9328EDFD4F2Q36761429-20497360-A083-4963-8CEC-854D83BA97BBQ37030687-7656A339-C11E-4A7A-951A-285BAECCFA92Q37631061-922B23AC-E65A-4DFF-BA73-7D491966EF81Q43267025-7734FB5A-BAEB-4405-8DAD-2E6AB91B298DQ45394890-4DC3CF8F-25DD-40A6-BD85-7BC04ABA220CQ48334580-C176A70B-FEAA-4FAD-8937-DEAA6BBE5ED7
P2860
Safety and efficacy of drospirenone used in a continuous combination with 17beta-estradiol for prevention of postmenopausal osteoporosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Safety and efficacy of drospir ...... f postmenopausal osteoporosis.
@en
Safety and efficacy of drospir ...... f postmenopausal osteoporosis.
@nl
type
label
Safety and efficacy of drospir ...... f postmenopausal osteoporosis.
@en
Safety and efficacy of drospir ...... f postmenopausal osteoporosis.
@nl
prefLabel
Safety and efficacy of drospir ...... f postmenopausal osteoporosis.
@en
Safety and efficacy of drospir ...... f postmenopausal osteoporosis.
@nl
P2093
P2860
P1433
P1476
Safety and efficacy of drospir ...... f postmenopausal osteoporosis.
@en
P2093
P2860
P304
P356
10.1080/13697130310001651535
P577
2004-03-01T00:00:00Z